Home
Research
A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse Shape+ with Lidocaine versus Juvederm Voluma with Lidocaine for the Correction of Age-Related Midface Volume Deficit/Lipoatrophy at 6 and 12 Months Post-treatment

A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse Shape+ with Lidocaine versus Juvederm Voluma with Lidocaine for the Correction of Age-Related Midface Volume Deficit/Lipoatrophy at 6 and 12 Months Post-treatment

Inquire About This Study

Vince Bertucci, MD, FRCPC: Bertucci MedSpa
8333 Weston Road, Suite 100
Woodbridge, ON L4L 8E2
Phone: (905) 850-4415
Hours: Monday: 8 a.m.–5 p.m.
Tuesday: 9 a.m.–5 p.m.
Wednesday – Thursday: 8 a.m.–5 p.m.
Friday: 8 a.m.–4 p.m.

Trial Concludes: 08/31/2023

Evaluating the Safety and Efficacy of Revanesse Shape+ with Lidocaine versus Juvederm Voluma with Lidocaine for the Correction of Age-Related Midface Volume Deficit/Lipoatrophy

This study compared the safety and efficacy profiles of Revanesse Shape+ with Lidocaine versus Juvederm Voluma with Lidocaine for subcutaneous and/or supraperiosteal injection to improve appearance through the correction of age-related mid-face volume deficit in patients 22 years of age through 65 years of age.

Inquire About This Study